Nutanix (NTNX)

[admin]

Nutanix analyst commentary at Morgan Stanley  Despite some positive signs, Nutanix has 'more work to do,' says Morgan Stanley. Morgan Stanley analyst Katy Huberty said Nutanix management highlighted early positive signs of rebuilding the deal pipeline during the company's analyst day meeting, though investments in lead generation will take time to have an impact and the April quarter "will still be tough," she tells investors. Though she acknowledges execution remains a risk, Huberty looks to sales growth re-accelerating in the first half of 2020 and maintains an Overweight rating on Nutanix shares with a $53 price target following the analyst event.

Breaking News: NTNX latest news. - The Fly

Nutanix analyst commentary at JMP Securities  JMP says Nutanix plans to improve sales execution should help ease concerns. After attending Nutanix's analyst day, JMP Securities analyst Erik Suppiger attributes management having noted some initial signs of success in re-accelerating the company's lead generation as the primary driver for yesterday's strength in the stock during the event. However, management tried to temper near-term investor enthusiasm with its subsequent comments, he noted. Management laid out plans to improve sales execution in response to the company's disappointing Q2 report, which Suppiger thinks will help to ease investor concerns. The analyst, who thinks Nutanix's expanding product line and upcoming refresh cycle should help it achieve its $3B billings goal in 2021, keeps an Outperform rating and $52 price target on the shares.

Breaking News: NTNX latest news. - The Fly

Nutanix analyst commentary at Jefferies  Nutanix price target raised to $49 from $42 at Jefferies. Jefferies analyst John DiFucci raised his price target for Nutanix to $49 from $42 saying he left yesterday's investor day more encouraged that the company's "technology foundation" will carry it through the "go-to-market issues of late." Nutanix shares can be "purchased here for the long haul," DiFucci tells investors in a research note. He points out Nutanix provided modified long-term guidance, updating the timing on its $3B in total software and support billings to calendar 2021 from fiscal 2021. This implies a two quarter delay from prior guidance and represents annual growth of 33% from 2018 billings, the analyst says.

Breaking News: NTNX latest news. - The Fly